Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myeloma.
Nat. Cancer
2023
4
1
81-95
Author Correction: Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer.
Nat Med
2022
28
3
Inhibition of ADAM17 impairs endothelial cell necroptosis and blocks metastasis.
J Exp Med
2022
219
1
Automated detection of neutralizing SARS-CoV-2 antibodies in minutes using a competitive chemiluminescence immunoassay.
Anal Bioanal Chem
2023
415
3
391-404
TIMP-1 is a novel ligand of Amyloid Precursor Protein and triggers a proinflammatory phenotype in human monocytes.
J Cell Biol
2023
222
2
NCALD as a potential predictive biomarker for the efficacy of platinum-based chemotherapy in ovarian cancer.
Biomark Med
2022
16
14
1029-1041
Correction to: Mild COVID-19 imprints a long-term inflammatory eicosanoid- and chemokine memory in monocyte-derived macrophages.
Mucosal Immunol
2022
15
4
798-798
Alternative oxidase encoded by sequence-optimized and chemically-modified RNA transfected into mammalian cells is catalytically active.
Gene Ther
2022
29
12
655-664
Adaptive-like NK cell responses are composed of circulating and resident lineages
Eur J Immunol
2021
51 Suppl 1
38-38